TD Cowen Maintains Buy Rating on Exagen, Raises Target to $11
TD Cowen raised its Exagen price target to $11.00 per share from $10.00 while maintaining its Buy rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.